Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression
Viktor Umansky, C Blattner, Christoffer Gebhardt, et al.
Vaccines (2016) Vol. 4, Iss. 4, pp. 36-36
Open Access | Times Cited: 365

Showing 1-25 of 365 citing articles:

Myeloid-derived suppressor cells coming of age
Filippo Veglia, Michela Perego, Dmitry I. Gabrilovich
Nature Immunology (2018) Vol. 19, Iss. 2, pp. 108-119
Open Access | Times Cited: 1543
Extracellular Vesicle Heterogeneity: Subpopulations, Isolation Techniques, and Diverse Functions in Cancer Progression
Eduard Willms, Carlos Cabañas, Imre Mäger, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 812
Tumour-associated neutrophils in patients with cancer
Merav E. Shaul, Zvi G. Fridlender
Nature Reviews Clinical Oncology (2019) Vol. 16, Iss. 10, pp. 601-620
Closed Access | Times Cited: 769
Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation
Veronica Huber, Chiara Camisaschi, Angela Berzi, et al.
Seminars in Cancer Biology (2017) Vol. 43, pp. 74-89
Open Access | Times Cited: 510
Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression
Viktor Fleming, Xiaoying Hu, Rebekka Weber, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 402
Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer
Andrew M. K. Law, Fátima Valdés‐Mora, David Gallego‐Ortega
Cells (2020) Vol. 9, Iss. 3, pp. 561-561
Open Access | Times Cited: 382
Complement in cancer: untangling an intricate relationship
Edimara S. Reis, Dimitrios C. Mastellos, Daniel Ricklin, et al.
Nature reviews. Immunology (2017) Vol. 18, Iss. 1, pp. 5-18
Open Access | Times Cited: 357
Interleukin-8 in cancer pathogenesis, treatment and follow-up
Carlos Alfaro, Miguel F. Sanmamed, María E. Rodríguez-Ruiz, et al.
Cancer Treatment Reviews (2017) Vol. 60, pp. 24-31
Closed Access | Times Cited: 330
Neutrophils and PMN-MDSC: Their biological role and interaction with stromal cells
Jie Zhou, Yulia Nefedova, Aihua Lei, et al.
Seminars in Immunology (2017) Vol. 35, pp. 19-28
Open Access | Times Cited: 299
Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma
Veronica Huber, Viviana Vallacchi, Viktor Fleming, et al.
Journal of Clinical Investigation (2018) Vol. 128, Iss. 12, pp. 5505-5516
Open Access | Times Cited: 224
Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma
Areeg Elmusrati, Justin Wang, Cun‐Yu Wang
International Journal of Oral Science (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 199
Cancer‐related circulating and tumor‐associated neutrophils – subtypes, sources and function
Merav E. Shaul, Zvi G. Fridlender
FEBS Journal (2018) Vol. 285, Iss. 23, pp. 4316-4342
Open Access | Times Cited: 193
Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Matthew Dysthe, Robin Parihar
Advances in experimental medicine and biology (2020), pp. 117-140
Closed Access | Times Cited: 191
Papillomavirus Immune Evasion Strategies Target the Infected Cell and the Local Immune System
Chenhao Zhou, Zewen Kelvin Tuong, Ian H. Frazer
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 183
Exosomes Produced by Mesenchymal Stem Cells Drive Differentiation of Myeloid Cells into Immunosuppressive M2-Polarized Macrophages in Breast Cancer
Subir Biswas, Gunjan Mandal, Sougata Roy Chowdhury, et al.
The Journal of Immunology (2019) Vol. 203, Iss. 12, pp. 3447-3460
Open Access | Times Cited: 175
The Role of the Estrogen Pathway in the Tumor Microenvironment
Natalie J. Rothenberger, Ashwin Somasundaram, Laura P. Stabile
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 2, pp. 611-611
Open Access | Times Cited: 168
Targeting myeloid-derived suppressor cells using all-trans retinoic acid in melanoma patients treated with Ipilimumab
Richard P. Tobin, Kimberly R. Jordan, William A. Robinson, et al.
International Immunopharmacology (2018) Vol. 63, pp. 282-291
Open Access | Times Cited: 167
Chemokines and their receptors promoting the recruitment of myeloid-derived suppressor cells into the tumor
Baohua Li, Malgorzata Garstka, Zongfang Li
Molecular Immunology (2019) Vol. 117, pp. 201-215
Closed Access | Times Cited: 167
Metabolic crosstalk in the breast cancer microenvironment
Ana S. Dias, Catarina R. Almeida, Luísa A. Helguero, et al.
European Journal of Cancer (2019) Vol. 121, pp. 154-171
Closed Access | Times Cited: 164
Managing the TME to improve the efficacy of cancer therapy
Maria Teresa Bilotta, Antonella Antignani, David Fitzgerald
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 140
Targeting tumor-derived NLRP3 reduces melanoma progression by limiting MDSCs expansion
Isak W. Tengesdal, Dinoop Ravindran Menon, Douglas G. Osborne, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 10
Open Access | Times Cited: 139
High fat diet, gut microbiome and gastrointestinal cancer
Yao Tong, Huiru Gao, Qiuchen Qi, et al.
Theranostics (2021) Vol. 11, Iss. 12, pp. 5889-5910
Open Access | Times Cited: 129
Estrogen Receptor Signaling in the Immune System
Binita Chakraborty, Jovita Byemerwa, Taylor Krebs, et al.
Endocrine Reviews (2022) Vol. 44, Iss. 1, pp. 117-141
Open Access | Times Cited: 113
Immunosuppression in Glioblastoma: Current Understanding and Therapeutic Implications
Benjamin Himes, Philipp Geiger, Katayoun Ayasoufi, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 110
Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target
Feyza Gül Özbay Kurt, Samantha Lasser, Ihor Arkhypov, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 13
Open Access | Times Cited: 61
Page 1 - Next Page

Scroll to top